Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants
Status:
Completed
Trial end date:
2019-07-11
Target enrollment:
Participant gender:
Summary
This is an ADME study. Human radiolabeled mass balance studies are performed as part of drug
development to obtain information about the absorption, distribution, metabolism, and
excretion (ADME) of a study treatment. The goals of human ADME studies include the assessment
of absorption, distribution, routes and rates of excretion, mass balance, and metabolite
profile and identification.